Vivitrol: all 37 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1TerminatedNCT04480554Phase 2Results posted
• Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use DisorderTerminatedNCT04094584Phase 4Results posted
• Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSDTerminatedNCT03852628Phase 2Results posted
• A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine RespondersCompletedNCT03232346Phase 3Results posted
• Buprenorphine as Adjunct to Outpatient Induction Onto VivitrolTerminatedNCT03113409Phase 2/3Results posted
• Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use DisorderCompletedNCT03078075Phase 3Results posted
• Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court SettingsCompletedNCT02978417Phase 4Results posted
• Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable NaltrexoneCompletedNCT02617628Phase 2/3Results posted
• Alcohol Disorder hOsPital Treatment TrialCompletedNCT02478489Phase 4Results posted
• Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department UsersCompletedNCT02445339Phase 4Results posted
• Study of Long-Acting Injectable Naltrexone to Treat Cannabis DependenceCompletedNCT02088177Phase 1/2Results posted
• Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness StudyCompletedNCT01908062Phase 3Results posted
• Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary CareCompletedNCT01893827Phase 4Results posted
• Extended Release Naltrexone for Opioid-Dependent YouthCompletedNCT01843023Phase 4Results posted
• Risky Decision Making in Methamphetamine Users: The Role of Opioid BlockadeCompletedNCT01822132Not applicableResults posted
• Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid DependenceCompletedNCT01690546Phase 2Results posted
• CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and RecoveryCompletedNCT01587196Phase 2Results posted
• The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid DependenceCompletedNCT01556425Phase 2Results posted
• A Study of VIVITROL in the Prevention of Re-arrest and Re-incarcerationCompletedNCT01453374Phase 4Results posted
• ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)CompletedNCT01218997Phase 3Results posted
• ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use OpioidsCompletedNCT01218984Phase 2Results posted
• ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)CompletedNCT01218971Phase 3Results posted
• ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent AdultsCompletedNCT01218958Phase 3Results posted
• Alcohol Pharmacotherapy for HIV+ PrisonersCompletedNCT01077310Not applicableResults posted
• ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care ProfessionalsCompletedNCT00834080Phase 3Results posted
• VIVITROL as a Treatment for Cocaine and Alcohol DependenceCompletedNCT00777062Phase 2Results posted
• ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid DependenceCompletedNCT00678418Phase 3Results posted
• Extended-release Naltrexone for Alcohol Dependence in Primary CareCompletedNCT00620750Phase 4Results posted
• Vivitrol for Reducing Driving While Impaired Behavior Among Repeat OffendersCompletedNCT00537745Phase 4Results posted
• ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent AdultsCompletedNCT00511836Phase 4Results posted
• ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced AbstinenceCompletedNCT00501631Phase 3Results posted
• ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])TerminatedNCT00156936Phase 3Results posted
• ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent AdultsCompletedNCT00156923Phase 3Results posted
• Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use DisorderActive, not recruitingNCT06233799Phase 3
• Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and RecoveryCompletedNCT03647774Phase 4
• Pre-Release VIVITROL for Opioid Dependent InmatesCompletedNCT01563718Phase 4
• Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in RussiaCompletedNCT01389167Phase 3

← Vivitrol overview